» Articles » PMID: 31944624

Detection and Quantitation of Synthetic Cannabinoid Receptor Agonists in Infused Papers from Prisons in a Constantly Evolving Illicit Market

Overview
Journal Drug Test Anal
Specialties Chemistry
Pharmacology
Date 2020 Jan 17
PMID 31944624
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Drug misuse in prisons contributes to increased disruption and violence and negatively impacts prisoner safety, rehabilitation, and recovery. Synthetic cannabinoid receptor agonists (SCRAs), colloquially known as "spice", are infused into papers and are of particular concern in a prison setting where they are commonly vaped. Methods for the qualitative and quantitative analysis of SCRA infused papers, including impurity profiling, were developed using gas chromatography-mass spectrometry (GC-MS) with qualitative confirmation by ultra high pressure liquid chromatography with photodiode array and quadrupole time of flight mass spectrometry detection (UPLC-PDA-QToF-MS) and applied to 354 individual seized paper samples originating from 168 seizures from three Scottish prisons. Of these samples, 41% (146 samples from 101 seizures) contained at least one SCRA and multiple SCRAs were detected on 23% of these papers. Concentrations ranged from < 0.05-1.17 mg/cm paper, representing the first reported quantitative data for SCRA infused papers. An evolution in the SCRAs detected was demonstrated; 5F-MDMB-PINACA (5F-ADB) predominated until late 2018, after which time 5F-MDMB-PICA and 4F-MDMB-BINACA became increasingly more prevalent, followed by the arrival of MDMB-4en-PINACA in June 2019. Concentration mapping data from two seized paper samples demonstrated that SCRA concentrations across larger papers were highly variable (0.47-2.38 mg/cm paper) making consistent dosing by users, and representative sampling by laboratory analysts, difficult. Near real-time qualitative and quantitative information on SCRAs circulating in prisons acts as an early warning system for SCRAs emerging on the wider illicit market, inform the methods used to detect them and limit supply, and provide information to support harm reduction measures.

Citing Articles

Identification and Health Risks of an Emerging Means of Drug Use in Correctional Facilities.

Kuai D, Rivera Blanco L, Krotulski A, Walton S, Denn M, Kelly B JAMA Netw Open. 2024; 7(12):e2451951.

PMID: 39714837 PMC: 11667344. DOI: 10.1001/jamanetworkopen.2024.51951.


[Simultaneous determination of 102 synthetic cannabinoids in electronic cigarette oil by liquid chromatography-tandem mass spectrometry].

Yang Z, Jiang L, Yang S, Wu Y, Lyu J Se Pu. 2024; 42(10):943-953.

PMID: 39327658 PMC: 11439141. DOI: 10.3724/SP.J.1123.2024.03017.


Cannabis as a Source of Approved Drugs: A New Look at an Old Problem.

Gabarin A, Yarmolinsky L, Budovsky A, Khalfin B, Ben-Shabat S Molecules. 2023; 28(23).

PMID: 38067416 PMC: 10707504. DOI: 10.3390/molecules28237686.


Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB receptor.

Patel M, Grimsey N, Banister S, Finlay D, Glass M Pharmacol Res Perspect. 2023; 11(6):e01157.

PMID: 38018694 PMC: 10685394. DOI: 10.1002/prp2.1157.


Instant Detection of Synthetic Cannabinoids on Physical Matrices, Implemented on a Low-Cost, Ultraportable Device.

Cozier G, Andrews R, Frinculescu A, Kumar R, May B, Tooth T Anal Chem. 2023; 95(37):13829-13837.

PMID: 37642957 PMC: 10515102. DOI: 10.1021/acs.analchem.3c01844.